Pandion Therapeutics is still in the earliest stage of testing its lead drug candidate in humans, but Merck sees enough potential...
Digital health titans Teladoc Health and Livongo are merging under the Teladoc name. The deal values the 12-year-old digital chronic care-management company...
Dive Brief: Teladoc Health is buying digital chronic disease management company Livongo in an $18.5 billion cash and stock deal, the companies...
In one of the biggest ever digital health deals in history, Teladoc announced Wednesday it would acquire Livongo, valuing the company...
Two digital health giants will merge in one of the largest deals seen in the sector. Livongo, which has seen success with...